Freshpet Stock: A Tale of Woe and Wagging Tails

Enter Robert Moskow, an analyst at TD Cowen, whose quill drips not with ink but with the acid of skepticism. This modern-day scribe has declared Freshpet guilty-not of malice, mind you, but of mediocrity. He slashed his price target from $72 to $63 per share, leaving behind a faint whiff of disdain. His verdict? “Hold,” he decrees, as if advising one to clutch tightly to a soggy biscuit rather than cast it aside.








